A study to investigate the effect of MEDI0382 on hepatic glycogen metabolism in overweight and obese subjects with Type 2 Diabetes Mellitus.

Trial Identifier: D5670C00022
Sponsor: MedImmune, LLC
NCTID:: NCT03555994
Start Date: May 2018
Primary Completion Date: April 2021
Study Completion Date: April 2021
Condition: Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English version Part A
English version Part B
Dutch Translation Part A
Swedish Translation Part A
Dutch Translation Part B
Swedish Translation Part B

Trial Locations

Country Location
GB Nottingham, GB, NG7 2UH
NL Maastricht, NL, 6229 ER
SE Uppsala, SE, 752 37